Structure

Physi-Chem Properties

Molecular Weight:  189.08
Volume:  197.094
LogP:  1.968
LogD:  2.125
LogS:  -2.406
# Rotatable Bonds:  3
TPSA:  53.09
# H-Bond Aceptor:  3
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.777
Synthetic Accessibility Score:  1.718
Fsp3:  0.182
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.497
MDCK Permeability:  1.0948709132208023e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.709

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.403
Plasma Protein Binding (PPB):  88.77806854248047%
Volume Distribution (VD):  0.266
Pgp-substrate:  8.048563003540039%

ADMET: Metabolism

CYP1A2-inhibitor:  0.229
CYP1A2-substrate:  0.333
CYP2C19-inhibitor:  0.082
CYP2C19-substrate:  0.063
CYP2C9-inhibitor:  0.027
CYP2C9-substrate:  0.964
CYP2D6-inhibitor:  0.088
CYP2D6-substrate:  0.747
CYP3A4-inhibitor:  0.014
CYP3A4-substrate:  0.071

ADMET: Excretion

Clearance (CL):  6.017
Half-life (T1/2):  0.901

ADMET: Toxicity

hERG Blockers:  0.027
Human Hepatotoxicity (H-HT):  0.252
Drug-inuced Liver Injury (DILI):  0.169
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.744
Maximum Recommended Daily Dose:  0.346
Skin Sensitization:  0.368
Carcinogencity:  0.19
Eye Corrosion:  0.027
Eye Irritation:  0.911
Respiratory Toxicity:  0.328

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC78020

Natural Product ID:  NPC78020
Common Name*:   Indolylpropionic Acid
IUPAC Name:   3-(1H-indol-3-yl)propanoic acid
Synonyms:   3-Indolepropionicacid; Indole-3-Propionic Acid
Standard InCHIKey:  GOLXRNDWAUTYKT-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C11H11NO2/c13-11(14)6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6H2,(H,13,14)
SMILES:  OC(=O)CCc1c[nH]c2c1cccc2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL207225
PubChem CID:   3744
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0001290] Indolyl carboxylic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3926 Cell Line Mixed cortical cells Rattus norvegicus Inhibition = 87.7 % PMID[470202]
NPT3926 Cell Line Mixed cortical cells Rattus norvegicus Inhibition = 83.8 % PMID[470202]
NPT3926 Cell Line Mixed cortical cells Rattus norvegicus Inhibition = 76.1 % PMID[470202]
NPT3170 Individual Protein Kynurenine--oxoglutarate transaminase I Homo sapiens IC50 = 140000.0 nM PMID[470204]
NPT65 Cell Line HepG2 Homo sapiens CC50 > 1000000.0 nM PMID[470207]
NPT35 Others n.a. Ki = 22908676527.68 nM PMID[470202]
NPT1 Others Radical scavenging activity Activity = 95.7 nM PMID[470202]
NPT1 Others Radical scavenging activity Activity = 96.5 nM PMID[470202]
NPT3927 Organism Rotifers Rotifera Activity = 67.9 % PMID[470202]
NPT3927 Organism Rotifers Rotifera Activity = 53.8 % PMID[470202]
NPT27 Others Unspecified LogP app = -5.68 n.a. PMID[470203]
NPT35 Others n.a. LogP = 1.75 n.a. PMID[470203]
NPT2 Others Unspecified IC50 > 1000000.0 nM PMID[470205]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -17.48 % PMID[470206]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC50 = 68000.0 nM PMID[470207]
NPT27 Others Unspecified F = 30.0 % PMID[470207]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis FC = 7.0 n.a. PMID[470207]
NPT20556 SINGLE PROTEIN Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 10.15 % PMID[470208]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -0.15 % PMID[470209]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 IC50 > 20000.0 nM PMID[470210]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 IC50 > 19952.62 nM PMID[470210]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC78020 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9744 High Similarity NPC110500
0.9744 High Similarity NPC203468
0.9744 High Similarity NPC149155
0.9682 High Similarity NPC267885
0.956 High Similarity NPC55772
0.956 High Similarity NPC126709
0.956 High Similarity NPC248041
0.956 High Similarity NPC283219
0.9497 High Similarity NPC111275
0.9255 High Similarity NPC145885
0.9255 High Similarity NPC84827
0.9255 High Similarity NPC14113
0.9212 High Similarity NPC235684
0.9212 High Similarity NPC315555
0.9198 High Similarity NPC213468
0.9102 High Similarity NPC321708
0.8982 High Similarity NPC62749
0.897 High Similarity NPC71037
0.8924 High Similarity NPC279918
0.8868 High Similarity NPC282231
0.8788 High Similarity NPC217372
0.8788 High Similarity NPC15573
0.8788 High Similarity NPC183662
0.8786 High Similarity NPC179701
0.8742 High Similarity NPC230869
0.8736 High Similarity NPC272483
0.8736 High Similarity NPC262898
0.8735 High Similarity NPC219336
0.8726 High Similarity NPC73952
0.8726 High Similarity NPC469765
0.8726 High Similarity NPC469763
0.8726 High Similarity NPC25008
0.8726 High Similarity NPC469760
0.8726 High Similarity NPC259644
0.8726 High Similarity NPC469786
0.8713 High Similarity NPC83111
0.8704 High Similarity NPC160105
0.8704 High Similarity NPC474561
0.8704 High Similarity NPC49954
0.8704 High Similarity NPC54988
0.8679 High Similarity NPC469762
0.8671 High Similarity NPC70922
0.8671 High Similarity NPC75540
0.8671 High Similarity NPC212376
0.8671 High Similarity NPC80597
0.8671 High Similarity NPC211572
0.865 High Similarity NPC63751
0.8616 High Similarity NPC469785
0.8596 High Similarity NPC278434
0.8588 High Similarity NPC213308
0.8588 High Similarity NPC45459
0.8588 High Similarity NPC315491
0.8581 High Similarity NPC314372
0.858 High Similarity NPC469358
0.8571 High Similarity NPC190296
0.8497 Intermediate Similarity NPC154339
0.8494 Intermediate Similarity NPC314603
0.8488 Intermediate Similarity NPC17059
0.8466 Intermediate Similarity NPC194640
0.8466 Intermediate Similarity NPC311276
0.8462 Intermediate Similarity NPC159856
0.8457 Intermediate Similarity NPC131718
0.8457 Intermediate Similarity NPC88315
0.8421 Intermediate Similarity NPC228835
0.8418 Intermediate Similarity NPC227582
0.8402 Intermediate Similarity NPC11126
0.8398 Intermediate Similarity NPC473376
0.8389 Intermediate Similarity NPC476874
0.8354 Intermediate Similarity NPC102423
0.8354 Intermediate Similarity NPC40779
0.8353 Intermediate Similarity NPC469896
0.8352 Intermediate Similarity NPC267343
0.8343 Intermediate Similarity NPC59269
0.8343 Intermediate Similarity NPC248454
0.8333 Intermediate Similarity NPC213629
0.8315 Intermediate Similarity NPC156704
0.8313 Intermediate Similarity NPC201700
0.8306 Intermediate Similarity NPC88008
0.8305 Intermediate Similarity NPC202812
0.8301 Intermediate Similarity NPC96102
0.8301 Intermediate Similarity NPC261195
0.8301 Intermediate Similarity NPC29886
0.8278 Intermediate Similarity NPC252338
0.8268 Intermediate Similarity NPC67288
0.8268 Intermediate Similarity NPC131887
0.825 Intermediate Similarity NPC105818
0.825 Intermediate Similarity NPC24678
0.8247 Intermediate Similarity NPC105127
0.8247 Intermediate Similarity NPC84911
0.8239 Intermediate Similarity NPC138370
0.8239 Intermediate Similarity NPC471957
0.8222 Intermediate Similarity NPC293917
0.8218 Intermediate Similarity NPC94752
0.8216 Intermediate Similarity NPC478158
0.8198 Intermediate Similarity NPC233936
0.8193 Intermediate Similarity NPC42372
0.8187 Intermediate Similarity NPC476073
0.8167 Intermediate Similarity NPC171317
0.8158 Intermediate Similarity NPC82295
0.8156 Intermediate Similarity NPC11445
0.815 Intermediate Similarity NPC163055
0.8141 Intermediate Similarity NPC110126
0.8141 Intermediate Similarity NPC73767
0.8128 Intermediate Similarity NPC82370
0.8125 Intermediate Similarity NPC175474
0.8103 Intermediate Similarity NPC165495
0.8101 Intermediate Similarity NPC195239
0.8101 Intermediate Similarity NPC157828
0.8089 Intermediate Similarity NPC469779
0.8089 Intermediate Similarity NPC469767
0.8089 Intermediate Similarity NPC469780
0.8089 Intermediate Similarity NPC469783
0.8089 Intermediate Similarity NPC469784
0.8089 Intermediate Similarity NPC469761
0.8089 Intermediate Similarity NPC469768
0.8089 Intermediate Similarity NPC279081
0.8086 Intermediate Similarity NPC216713
0.8085 Intermediate Similarity NPC207020
0.8081 Intermediate Similarity NPC248462
0.8059 Intermediate Similarity NPC313791
0.8057 Intermediate Similarity NPC314002
0.8057 Intermediate Similarity NPC188387
0.8057 Intermediate Similarity NPC280290
0.8057 Intermediate Similarity NPC163421
0.8049 Intermediate Similarity NPC285469
0.8046 Intermediate Similarity NPC220765
0.8042 Intermediate Similarity NPC54744
0.8042 Intermediate Similarity NPC229348
0.8038 Intermediate Similarity NPC469766
0.8023 Intermediate Similarity NPC64436
0.8023 Intermediate Similarity NPC151939
0.8022 Intermediate Similarity NPC74413
0.8012 Intermediate Similarity NPC293216
0.8 Intermediate Similarity NPC313640
0.8 Intermediate Similarity NPC478157
0.8 Intermediate Similarity NPC204717
0.7989 Intermediate Similarity NPC193761
0.7975 Intermediate Similarity NPC230002
0.7966 Intermediate Similarity NPC317030
0.7966 Intermediate Similarity NPC46580
0.7952 Intermediate Similarity NPC135141
0.7952 Intermediate Similarity NPC92796
0.7931 Intermediate Similarity NPC300688
0.7931 Intermediate Similarity NPC91179
0.7927 Intermediate Similarity NPC200214
0.7919 Intermediate Similarity NPC184964
0.7919 Intermediate Similarity NPC284775
0.7914 Intermediate Similarity NPC54420
0.791 Intermediate Similarity NPC474707
0.791 Intermediate Similarity NPC171171
0.7907 Intermediate Similarity NPC469938
0.7898 Intermediate Similarity NPC477003
0.7895 Intermediate Similarity NPC75634
0.7892 Intermediate Similarity NPC260900
0.7877 Intermediate Similarity NPC329858
0.7877 Intermediate Similarity NPC314333
0.7876 Intermediate Similarity NPC281049
0.7869 Intermediate Similarity NPC473640
0.7869 Intermediate Similarity NPC50503
0.7869 Intermediate Similarity NPC52557
0.7865 Intermediate Similarity NPC204565
0.7857 Intermediate Similarity NPC16667
0.7853 Intermediate Similarity NPC15102
0.784 Intermediate Similarity NPC143872
0.784 Intermediate Similarity NPC288838
0.7838 Intermediate Similarity NPC475506
0.7838 Intermediate Similarity NPC300183
0.7831 Intermediate Similarity NPC162860
0.7826 Intermediate Similarity NPC241024
0.7826 Intermediate Similarity NPC100321
0.7821 Intermediate Similarity NPC65215
0.7821 Intermediate Similarity NPC102338
0.7821 Intermediate Similarity NPC196251
0.7821 Intermediate Similarity NPC111602
0.7821 Intermediate Similarity NPC173028
0.7821 Intermediate Similarity NPC63199
0.7819 Intermediate Similarity NPC323927
0.7802 Intermediate Similarity NPC276517
0.7802 Intermediate Similarity NPC294693
0.7796 Intermediate Similarity NPC155143
0.7791 Intermediate Similarity NPC470498
0.7791 Intermediate Similarity NPC469811
0.779 Intermediate Similarity NPC55493
0.779 Intermediate Similarity NPC477167
0.779 Intermediate Similarity NPC47190
0.779 Intermediate Similarity NPC473342
0.779 Intermediate Similarity NPC99666
0.7784 Intermediate Similarity NPC129721
0.7784 Intermediate Similarity NPC470497
0.7784 Intermediate Similarity NPC195461
0.7784 Intermediate Similarity NPC81654
0.7784 Intermediate Similarity NPC470677
0.7784 Intermediate Similarity NPC249150
0.7784 Intermediate Similarity NPC49196
0.7784 Intermediate Similarity NPC313985
0.7784 Intermediate Similarity NPC79129
0.7778 Intermediate Similarity NPC95783
0.7778 Intermediate Similarity NPC171787
0.7772 Intermediate Similarity NPC306376
0.7772 Intermediate Similarity NPC470499

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC78020 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9744 High Similarity NPD482 Approved
0.9682 High Similarity NPD749 Clinical (unspecified phase)
0.9383 High Similarity NPD2095 Phase 2
0.9383 High Similarity NPD2092 Phase 2
0.9383 High Similarity NPD2094 Phase 2
0.9325 High Similarity NPD2091 Phase 2
0.9325 High Similarity NPD2096 Phase 2
0.9308 High Similarity NPD750 Phase 2
0.903 High Similarity NPD5728 Clinical (unspecified phase)
0.8598 High Similarity NPD4184 Clinical (unspecified phase)
0.8588 High Similarity NPD484 Approved
0.8398 Intermediate Similarity NPD5901 Discontinued
0.8385 Intermediate Similarity NPD276 Clinical (unspecified phase)
0.8301 Intermediate Similarity NPD198 Clinical (unspecified phase)
0.8251 Intermediate Similarity NPD4862 Clinical (unspecified phase)
0.8246 Intermediate Similarity NPD6595 Phase 3
0.8222 Intermediate Similarity NPD7621 Clinical (unspecified phase)
0.8204 Intermediate Similarity NPD2844 Phase 3
0.8172 Intermediate Similarity NPD7825 Clinical (unspecified phase)
0.8172 Intermediate Similarity NPD7998 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD786 Approved
0.8128 Intermediate Similarity NPD7470 Discontinued
0.8128 Intermediate Similarity NPD8013 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD5426 Phase 3
0.8087 Intermediate Similarity NPD8073 Approved
0.8043 Intermediate Similarity NPD8072 Approved
0.8038 Intermediate Similarity NPD1722 Approved
0.8023 Intermediate Similarity NPD2144 Approved
0.8012 Intermediate Similarity NPD5065 Approved
0.7989 Intermediate Similarity NPD3178 Discontinued
0.7966 Intermediate Similarity NPD8431 Approved
0.7962 Intermediate Similarity NPD2896 Discontinued
0.7957 Intermediate Similarity NPD7957 Phase 1
0.7957 Intermediate Similarity NPD7958 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD6610 Clinical (unspecified phase)
0.7921 Intermediate Similarity NPD8110 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD6203 Clinical (unspecified phase)
0.7906 Intermediate Similarity NPD8112 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6178 Phase 3
0.7886 Intermediate Similarity NPD3038 Discontinued
0.7877 Intermediate Similarity NPD4499 Approved
0.7857 Intermediate Similarity NPD7818 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD1534 Approved
0.7819 Intermediate Similarity NPD8493 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD7971 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD7970 Approved
0.7802 Intermediate Similarity NPD7618 Phase 3
0.7802 Intermediate Similarity NPD7619 Phase 3
0.7801 Intermediate Similarity NPD7594 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.7789 Intermediate Similarity NPD7809 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD4600 Approved
0.7784 Intermediate Similarity NPD4601 Approved
0.7778 Intermediate Similarity NPD5069 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD2121 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD3100 Discontinued
0.7744 Intermediate Similarity NPD4374 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD7903 Clinical (unspecified phase)
0.7735 Intermediate Similarity NPD6630 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD1326 Approved
0.7733 Intermediate Similarity NPD1325 Approved
0.7713 Intermediate Similarity NPD8272 Phase 2
0.7701 Intermediate Similarity NPD5721 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD2172 Phase 1
0.7684 Intermediate Similarity NPD7947 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD4076 Approved
0.767 Intermediate Similarity NPD4079 Approved
0.765 Intermediate Similarity NPD5575 Clinical (unspecified phase)
0.765 Intermediate Similarity NPD1038 Approved
0.7641 Intermediate Similarity NPD5818 Discontinued
0.7632 Intermediate Similarity NPD6838 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD6664 Approved
0.7622 Intermediate Similarity NPD7948 Phase 1
0.7614 Intermediate Similarity NPD3506 Approved
0.7614 Intermediate Similarity NPD3505 Approved
0.7611 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD7944 Discontinued
0.7594 Intermediate Similarity NPD2305 Discontinued
0.7594 Intermediate Similarity NPD8248 Clinical (unspecified phase)
0.7592 Intermediate Similarity NPD2510 Approved
0.7592 Intermediate Similarity NPD2509 Approved
0.759 Intermediate Similarity NPD4462 Approved
0.759 Intermediate Similarity NPD4463 Approved
0.7588 Intermediate Similarity NPD1403 Approved
0.7588 Intermediate Similarity NPD1404 Approved
0.7584 Intermediate Similarity NPD4383 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD4948 Discontinued
0.7557 Intermediate Similarity NPD4075 Phase 2
0.7551 Intermediate Similarity NPD8406 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD4345 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.754 Intermediate Similarity NPD6661 Clinical (unspecified phase)
0.7527 Intermediate Similarity NPD5003 Discontinued
0.7526 Intermediate Similarity NPD6987 Phase 1
0.7514 Intermediate Similarity NPD7865 Approved
0.7514 Intermediate Similarity NPD5611 Phase 2
0.7513 Intermediate Similarity NPD8405 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5322 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2837 Discontinued
0.7485 Intermediate Similarity NPD1592 Phase 3
0.7459 Intermediate Similarity NPD802 Phase 2
0.7458 Intermediate Similarity NPD6375 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD5257 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD6999 Discontinued
0.7447 Intermediate Similarity NPD7000 Clinical (unspecified phase)
0.7446 Intermediate Similarity NPD2336 Approved
0.7436 Intermediate Similarity NPD8093 Discontinued
0.743 Intermediate Similarity NPD8464 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD2642 Approved
0.7414 Intermediate Similarity NPD2639 Approved
0.7411 Intermediate Similarity NPD3389 Approved
0.7411 Intermediate Similarity NPD3393 Approved
0.7411 Intermediate Similarity NPD3394 Approved
0.7407 Intermediate Similarity NPD4501 Approved
0.7407 Intermediate Similarity NPD4500 Approved
0.7405 Intermediate Similarity NPD6665 Discontinued
0.7405 Intermediate Similarity NPD5505 Discontinued
0.7401 Intermediate Similarity NPD4128 Approved
0.7399 Intermediate Similarity NPD1631 Approved
0.7398 Intermediate Similarity NPD8094 Discontinued
0.7394 Intermediate Similarity NPD751 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD2564 Approved
0.7391 Intermediate Similarity NPD2565 Phase 2
0.7386 Intermediate Similarity NPD5934 Clinical (unspecified phase)
0.7377 Intermediate Similarity NPD3961 Discontinued
0.7374 Intermediate Similarity NPD8386 Phase 2
0.7371 Intermediate Similarity NPD2640 Approved
0.7371 Intermediate Similarity NPD2641 Approved
0.7371 Intermediate Similarity NPD2185 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD1304 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD4703 Approved
0.7365 Intermediate Similarity NPD4702 Approved
0.7353 Intermediate Similarity NPD2809 Approved
0.7341 Intermediate Similarity NPD972 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7234 Approved
0.7337 Intermediate Similarity NPD7233 Approved
0.7333 Intermediate Similarity NPD5897 Approved
0.7333 Intermediate Similarity NPD5898 Approved
0.7333 Intermediate Similarity NPD5899 Approved
0.733 Intermediate Similarity NPD1573 Approved
0.733 Intermediate Similarity NPD1575 Approved
0.7318 Intermediate Similarity NPD4181 Approved
0.7316 Intermediate Similarity NPD6479 Discontinued
0.7312 Intermediate Similarity NPD3404 Approved
0.7303 Intermediate Similarity NPD4736 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD3323 Discontinued
0.7287 Intermediate Similarity NPD2307 Discontinued
0.7283 Intermediate Similarity NPD3486 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7866 Approved
0.7262 Intermediate Similarity NPD1661 Suspended
0.7257 Intermediate Similarity NPD1568 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD7711 Discontinued
0.7241 Intermediate Similarity NPD1853 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD4602 Approved
0.7234 Intermediate Similarity NPD4427 Phase 2
0.7225 Intermediate Similarity NPD5043 Discontinued
0.7225 Intermediate Similarity NPD1630 Approved
0.722 Intermediate Similarity NPD6165 Phase 2
0.722 Intermediate Similarity NPD6164 Phase 2
0.7216 Intermediate Similarity NPD7001 Phase 3
0.7216 Intermediate Similarity NPD6732 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD992 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD991 Phase 2
0.7212 Intermediate Similarity NPD3943 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD4397 Phase 1
0.7205 Intermediate Similarity NPD1627 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD6176 Phase 1
0.72 Intermediate Similarity NPD5140 Approved
0.72 Intermediate Similarity NPD5138 Approved
0.7184 Intermediate Similarity NPD2511 Approved
0.7184 Intermediate Similarity NPD6454 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6242 Discontinued
0.7175 Intermediate Similarity NPD4640 Approved
0.7175 Intermediate Similarity NPD4639 Approved
0.7175 Intermediate Similarity NPD4638 Approved
0.7171 Intermediate Similarity NPD7603 Discontinued
0.7168 Intermediate Similarity NPD4326 Phase 2
0.7165 Intermediate Similarity NPD3947 Discontinued
0.7164 Intermediate Similarity NPD3354 Phase 2
0.7159 Intermediate Similarity NPD5744 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD3320 Approved
0.7158 Intermediate Similarity NPD3318 Approved
0.7158 Intermediate Similarity NPD3319 Phase 1
0.7158 Intermediate Similarity NPD5213 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD1037 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1291 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5975 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7666 Phase 3
0.7143 Intermediate Similarity NPD6452 Discontinued
0.7143 Intermediate Similarity NPD7665 Phase 2
0.7136 Intermediate Similarity NPD7730 Approved
0.7136 Intermediate Similarity NPD7731 Approved
0.7135 Intermediate Similarity NPD6217 Discontinued
0.7135 Intermediate Similarity NPD510 Phase 1
0.7134 Intermediate Similarity NPD200 Phase 2
0.7134 Intermediate Similarity NPD201 Phase 2
0.7129 Intermediate Similarity NPD7952 Approved
0.7129 Intermediate Similarity NPD7789 Approved
0.7129 Intermediate Similarity NPD7951 Approved
0.7129 Intermediate Similarity NPD7790 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data